[Survival time and influencing factors in multidrug-resistant tuberculosis patients in Wuhan, 2006-2014].

Wang, J J; Zhou, M L; Chen, C; Wu, G; Zuo, Y P; Ren, X; Chen, Z; Wang, W H

Wang, J J; Zhou, M L; Chen, C; Wu, G; Zuo, Y P; Ren, X; Chen, Z; Wang, W H.

Affiliation

Wang JJ; Wuhan Pulmonary Hospital/Wuhan Institute for Tuberculosis Control, Wuhan 430030, China.

Zhonghua Liu Xing Bing Xue Za Zhi ; 40(11): 1409-1413, 2019 Nov 10.

Article in Zh | MEDLINE | ID: mdl-31838813

Subject(s)

Antitubercular Agents/therapeutic use; Tuberculosis, Multidrug-Resistant/drug therapy; Tuberculosis, Multidrug-Resistant/mortality; Adult; Aged; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycobacterium tuberculosis/isolation & purification; Proportional Hazards Models; Risk Factors; Survival Rate; Time Factors; Treatment Outcome; Tuberculosis/drug therapy; Tuberculosis/mortality; Tuberculosis, Multidrug-Resistant/microbiology

Key words

Influential factors; Multidrug-resistant; Survival rate; Tuberculosis

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2019 Type: Article Affiliation country: China

Fulltext

XML

PubMed Links

Search on Google